Oryzon Genomics SA (ORYZF)
3.31
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Oryzon Genomics Net Income (TTM) : -2.774M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.774M |
| March 31, 2026 | -2.433M |
| December 31, 2025 | -2.789M |
| September 30, 2025 | -2.707M |
| June 30, 2025 | -4.453M |
| March 31, 2025 | -4.513M |
| December 31, 2024 | -3.969M |
| September 30, 2024 | -4.335M |
| June 30, 2024 | -4.138M |
| March 31, 2024 | -3.097M |
| December 31, 2023 | -3.601M |
| September 30, 2023 | -4.094M |
| June 30, 2023 | -3.577M |
| March 31, 2023 | -4.376M |
| December 31, 2022 | -4.459M |
| September 30, 2022 | -3.950M |
| Date | Value |
|---|---|
| June 30, 2022 | -2.346M |
| March 31, 2022 | -4.893M |
| September 30, 2021 | -4.413M |
| June 30, 2021 | -3.645M |
| March 31, 2021 | -4.829M |
| December 31, 2020 | -3.909M |
| September 30, 2020 | -3.606M |
| June 30, 2020 | -3.631M |
| March 31, 2020 | -4.028M |
| December 31, 2019 | -4.128M |
| September 30, 2019 | -3.940M |
| June 30, 2019 | -3.988M |
| March 31, 2019 | -1.488M |
| December 31, 2018 | -1.376M |
| September 30, 2018 | -1.314M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Pharma Mar SA | 65.32M |
| Grifols SA | 629.73M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alkermes Plc | 66.12M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |